±¹¼Ò¸¶ÃëÁ¦ ½ÃÀå(2025-2034³â) : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø
Local Anesthesia Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
»óǰÄÚµå : 1766340
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 135 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,765,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,439,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 11,647,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ±¹¼Ò¸¶ÃëÁ¦ ½ÃÀåÀº 2024³â¿¡´Â 44¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í CAGR 4.1%·Î ¼ºÀåÇÏ¿© 2034³â¿¡´Â 65¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

ÀÌ·¯ÇÑ ¼ºÀåÀº ´Ù¾çÇÑ ÀÇ·á½Ã¼³¿¡¼­ ¼ö¼úÀ̳ª Àúħ½À óġÀÇ °Ç¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ÁÖµÈ ¿äÀÎÀÔ´Ï´Ù. Á¤±âÀûÀÎ ÅëÁõ °ü¸®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ ±¹¼Ò¸¶ÃëÁ¦ÀÇ Çʿ伺Àº Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡´Â ±¹¼Ò¸¶ÃëÁ¦ÀÇ ±¤¹üÀ§ÇÑ »ç¿ëÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÅÈï±¹ ½ÃÀå¿¡¼­´Â ÇコÄɾî ÀÎÇÁ¶óÀÇ Á¤ºñ°¡ ÁøÇàµÇ¸é¼­ ¿Ü°ú Ä¡·áÀÇ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖ´Â °Íµµ ÀÌ·¯ÇÑ ¾àÁ¦°¡ ³Î¸® ä¿ëµÇ±â À§ÇÑ ±âȸ·Î À̾îÁö°í ÀÖ½À´Ï´Ù.

±¹¼Ò¸¶ÃëÁ¦ Market-IMG1

Á¶±â ȸº¹°ú ÀÔ¿ø ±â°£ÀÇ ´ÜÃàÀÌ Á߽õǴ °¡Ä¡°ü¿¡ ±Ù°ÅÇÑ ÇコÄɾî·ÎÀÇ Àüȯ¿¡ ÀÇÇØ ¸¹Àº Ä¡·á¿¡¼­ ±¹¼Ò ¸¶Ãë°¡ ¿ì¼±½ÃµÇ°í ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ¿¬±¸¿¡ Àû±ØÀûÀ¸·Î ÅõÀÚÇϰí ÀÖÀ¸¸ç, Á¤Ã¥ Áö¿ø°ú ½ÂÀÎ ±â°£ ´ÜÃà ¶ÇÇÑ Á¦Ç°¿¡ ´ëÇÑ Á¢±Ù¼º°ú ÀÓ»ó ÀÌ¿ëÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 44¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 65¾ï ´Þ·¯
CAGR 4.1%

±¹¼Ò ¸¶Ãë´Â ȯÀÚÀÇ Àü¹ÝÀûÀÎ ÀǽĿ¡ ¿µÇâÀ» ÁÖÁö ¾Ê°í ½ÅüÀÇ Æ¯Á¤ ºÎÀ§¸¦ ¸¶ºñ½ÃŰ´Â ¾à¹°ÀÇ Åõ¿©¸¦ ¸»ÇÕ´Ï´Ù. ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â ¾à¹°¿¡´Â ºÎÇǹÙÄ«ÀÎ, ¸®µµÄ«ÀÎ, ÇÁ¸®·ÎÄ«ÀÎ, ·ÎÇǹÙÄ«ÀÎ, º¥Á¶Ä«ÀÎ, Ŭ·Î·ÎÇÁ·ÎÄ«ÀÎ µîÀÌ ÀÖ½À´Ï´Ù.

¸¶ÃëÁ¦ À¯Çü¿¡ µû¶ó ½ÃÀåÀº ºÎÇǹÙÄ«ÀÎ, ¸®µµÄ«ÀÎ, º¥Á¶Ä«ÀÎ, ÇÁ¸®·ÎÄ«ÀÎ, ·ÎÇǹÙÄ«ÀÎ, Ŭ·Î·ÎÇÁ·ÎÄ«ÀÎ ¹× ±âŸ º¯Á¾À¸·Î ±¸ºÐµË´Ï´Ù. ¸®µµÄ«ÀÎÀº ¼ÓÈ¿¼º, ¹ü¿ë¼º, Æø³ÐÀº ¿ëµµ·Î ÀÎÇØ ƯÈ÷ ¼Ò¼ö¼ú, ÇǺΰú, Ä¡°ú, ÅëÁõ °ü¸® µî¿¡ °¡Àå ³Î¸® »ç¿ëµÇ°í ÀÖ´Â ±¹¼Ò¸¶ÃëÁ¦ÀÔ´Ï´Ù. ¸®µµÄ«ÀÎ Á¦Á¦´Â ÁÖ»çÁ¦¿Í ¿Ü¿ëÁ¦ ÇüÅ ¸ðµÎ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

Åõ¿© °æ·Î¿¡ µû¶ó ±¹¼Ò¸¶ÃëÁ¦´Â ÁÖ»ç À¯Çü°ú ±¹¼Ò À¯ÇüÀ¸·Î ³ª´¹´Ï´Ù. ÁÖ»ç À¯ÇüÀº ½Å°æÂ÷´Ü ¹× ¼Ò¿Ü°úÀû °³ÀÔ µî ¼ö¸¹Àº ÀÓ»ó óġ¿¡¼­ÀÇ ÀûÇÕ¼ºÀ¸·Î ÀÎÇØ ³Î¸® ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ¾à¹° Àü´Þ ¹æ¹ý°ú ¼­¹æÇü Á¦Á¦¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀÌ Æ¯È÷ ¿Ü·¡ ȯÀÚ³ª ¼ö¼ú Ä¡·áÀÇ ÇöÀå¿¡¼­ÀÇ ±¤¹üÀ§ÇÑ »ç¿ëÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¿ëµµº°·Î ½ÃÀåÀº ¿Ü°ú Ä¡·á, Ä¡°ú Ä¡·á, ¹Ì¿ë ¹× ÇǺΰú Ä¡·á, ÅëÁõ °ü¸® µîÀ¸·Î ºÐ·ùµË´Ï´Ù. Ä¡°ú Ä¡·á¿¡¼­´Â ¹ßÄ¡, ÃæÄ¡ ÃæÀü¹° µîÀÇ Ä¡·á Áß ºÒÄè°¨À» ÃÖ¼ÒÈ­ÇÔÀ¸·Î½á Ä¡·á¸¦ ¿ëÀÌÇÏ°Ô Çϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°·Î º¼ ¶§ ½ÃÀåÀº º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ¹× ±âŸ ÇコÄɾî Á¦°ø¾÷ü¸¦ Æ÷ÇÔÇÕ´Ï´Ù. º´¿øÀº ±¹¼Ò ¸¶Ã븦 ÇÊ¿ä·Î ÇÏ´Â ´Ù¾çÇÑ ¿Ü°ú ¼ö¼úÀ̳ª Áø´Ü óġ°¡ ÀÌ·ç¾îÁö´Â ÁÖ¿ä Àå¼Ò·Î °è¼ÓÇØ¼­ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â 17¾ï ´Þ·¯ÀÇ ¼öÀÍÀ» ¿Ã¸®¸é¼­ ¼¼°è ½ÃÀåÀ» ¼±µµÇϰí ÀÖÀ¸¸ç CAGR 3.8%·Î ¼ºÀåÇÏ¿© 2034³â¿¡´Â 24¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì¿¡¼­´Â ±¹¼Ò ¸¶Ã븦 »ç¿ëÇÏ´Â ÀÇ·á ¹× ¿Ü°ú ¼ö¼úÀÇ ºóµµ°¡ ³ôÀº Á¡ µîÀÇ ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù.

½ÃÀåÀº Àû´çÇÏ°Ô ÅëÇյǾî ÀÖÀ¸¸ç »óÀ§ 5°³ ȸ»ç¿¡¼­ ÀüüÀÇ ¾à 55%ÀÇ Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. Braun Melsungen, Septodont, Pacira Biosciences µîÀÇ ÁÖ¿ä ±â¾÷Àº ½ÃÀå Á¡À¯À²À» È®´ëÇϱâ À§ÇØ ±â¼ú Çõ½Å, ¼¼°èÀûÀÎ Á¸Àç°¨ ±¸Ãà, Àü·«Àû Á¦ÈÞ¿¡ µû¶ó °æÀïÀ» °è¼ÓÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¾àÁ¦ À¯Çüº°(2021-2034³â)

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Åõ¿© °æ·Îº°(2021-2034³â)

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¿ëµµº°(2021-2034³â)

Á¦8Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2021-2034³â)

Á¦9Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°(2021-2034³â)

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

CSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Local Anesthesia Drugs Market was valued at USD 4.4 billion in 2024 and is estimated to grow at a CAGR of 4.1% to reach USD 6.5 billion by 2034. This growth is largely attributed to the rising volume of surgeries and minimally invasive procedures across various healthcare facilities. As demand rises for targeted and short-term pain management in outpatient clinics, dental offices, and cosmetic treatment centers, the need for effective local anesthetics continues to grow steadily. An increasing preference for procedures that allow quicker patient recovery and avoid the risks associated with general anesthesia is helping drive the widespread use of local anesthetic formulations. The growing population of older adults, who often require site-specific surgeries with fewer systemic effects, is another factor contributing to the market expansion. Additionally, ongoing development in healthcare infrastructure and access to surgical care in emerging markets are creating favorable conditions for the broader adoption of these drugs.

Local Anesthesia Drugs Market - IMG1

The shift toward value-based healthcare, where quicker recovery and shorter hospital stays are emphasized, has made local anesthesia a preferred choice in many treatments. Pharmaceutical companies are actively investing in research to improve the efficacy, onset, and duration of anesthetic formulations, further boosting product accessibility and clinical use. Regulatory support and faster approval pathways are also playing a vital role in facilitating market penetration and technological innovation.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$4.4 Billion
Forecast Value$6.5 Billion
CAGR4.1%

Local anesthesia refers to the administration of drugs that numb a specific part of the body without affecting the patient's overall consciousness. These anesthetics come in various forms, including injections, topical solutions, and sprays. Commonly used drugs in this category include bupivacaine, lidocaine, prilocaine, ropivacaine, benzocaine, and chloroprocaine.

Based on drug type, the market is segmented into bupivacaine, lidocaine, benzocaine, prilocaine, ropivacaine, chloroprocaine, and other variants. Among these, the lidocaine segment led the market with a value of USD 1.5 billion in 2024 and is expected to grow to USD 2.2 billion by 2034, advancing at a CAGR of 3.7%. Lidocaine remains one of the most extensively used local anesthetics due to its rapid onset, versatility, and wide range of applications, particularly in minor surgeries, dermatology, dentistry, and pain management. The availability of both injectable and topical lidocaine formulations adds to its appeal in various medical specialties.

By route of administration, local anesthetics are divided into injectable and topical types. The injectable segment held the largest share of 65.3% in 2024 and is expected to maintain its dominance throughout the forecast period. Injectables are widely preferred for their quick action, precise targeting, and suitability across numerous clinical procedures, such as nerve blocks and minor surgical interventions. Continuous innovation in delivery methods and extended-release formulations is further supporting their widespread use, particularly in outpatient and surgical care settings.

In terms of application, the market is classified into surgical procedures, dental procedures, cosmetic and dermatological procedures, pain management, and others. Dental procedures emerged as the leading segment in 2024, accounting for 33.2% of the market and projected to reach USD 2.1 billion by 2034. Local anesthesia plays a critical role in facilitating dental care by minimizing discomfort during treatments such as root canals, extractions, and cavity fillings. This segment's prominence is fueled by the increasing global burden of oral health issues and greater access to routine dental care.

According to end use, the market includes hospitals, ambulatory surgical centers, and other healthcare providers. Hospitals represented the dominant share of 56.2% in 2024 and are expected to generate USD 3.8 billion in revenue by 2034, growing at a CAGR of 4.4%. Hospitals continue to serve as the primary site for various surgical and diagnostic procedures that demand the use of local anesthesia. The availability of advanced surgical infrastructure, trained professionals, and comprehensive medical services solidifies their position as a key end-user segment.

Regionally, North America led the global market with USD 1.7 billion in revenue in 2024 and is forecast to reach USD 2.4 billion by 2034, expanding at a CAGR of 3.8%. The region benefits from well-developed healthcare systems, increased awareness regarding localized pain management solutions, and a high frequency of medical and surgical procedures that utilize local anesthesia. Steady R&D activities and the presence of leading pharmaceutical players also contribute significantly to the region's market leadership.

The market is moderately consolidated, with the top five players accounting for approximately 55% of the overall share. Key companies such as Pfizer, Fresenius Kabi, B. Braun Melsungen, Septodont, and Pacira Biosciences continue to compete based on innovation, global presence, and strategic collaborations to capture greater market share. Their ongoing efforts in expanding product lines, entering new markets, and enhancing manufacturing capabilities are expected to influence market dynamics over the coming years.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2024

Chapter 5 Market Estimates and Forecast, By Drug Type, 2021 - 2034 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 - 2034 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

Chapter 10 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â